Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Pharma Tech
Podcast: An investor’s guide to preparing your clinical data package
Biotech investor Stephan Christgau speaks about the key considerations when devising a clinical strategy that will attract investor attention.
Read Full Article
Pharma Tech
Evommune signs $1.1bn licence deal with Hinova for EVO570
Evommune has secured exclusive rights outside Greater China to develop EVO570 from Hinova Pharmaceuticals in a deal worth up to $1.1bn.
Read Full Article
PharmaShots
Top 6 AI Phone Agents for Healthcare Practices
Each unanswered call at a medical practice is a patient who’ll simply dial the next clinic on their list. AI phone agents exist to fix that, picking up after hours, collecting intake details, and moving patients toward a booked appointment without hiring more staff. Six platforms stand out in 2026 for both small-to-mid-sized practices and… The post Top 6 AI Phone Agents for Healthcare Practices appeared first on PharmaShots.
Read Full Article
Pharma Tech
PharmatrophiX and Circular partner on neurodegenerative drugs
PharmatrophiX and Circular Genomics have partnered to advance blood-based circular RNA biomarkers in neurodegenerative drug development programmes.
Read Full Article
Express Pharma
HRV Pharma acquires Phatebo GmbH; enters European finished formulations market
Phatebo sources the comparator, investigational and ancillary medicines that pharmaceutical sponsors and clinical research organisations need to run their trials, and becomes HRV’s first finished formulations business in Europe The post HRV Pharma acquires Phatebo GmbH; enters European finished formulations market appeared first on Express Pharma.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
PharmaShots
Nov 5, 2026, 11:12 AM
Cloudbreak Reports P-III (CS-301) Topline Data of CBT-001 for Pterygium
Shots: Cloudbreak Pharma has reported topline results from its multi-regional, double-masked, randomized, vehicle-controlled P-III (CS-301) study of CBT-001 ophthalmic emulsion in pts with pterygium (n=659) Both CBT-001 0.1% & 0.2% BID met the 1EPs, showing statistically significant improvement in conjunctival hyperemia at Month 3 vs vehicle (p<0.001; benefit from Week 2 through Month 12) &… The post Cloudbreak Reports P-III (CS-301) Topline Data of CBT-001 for Pterygium appeared first on PharmaShots.
PharmaShots
Nov 5, 2026, 11:10 AM
Evommune Enters Exclusive License Agreement with Hinova for EVO570, an Oral VAV1 Molecular Glue Degrader
Shots: Evommune has entered into an exclusive license agreement with Hinova Pharmaceuticals for worldwide rights (ex-Greater China) to develop, manufacture & commercialize EVO570 (formerly HC118/HP570), an oral VAV1-directed molecular glue degrader Evommune will pay $30M upfront ($20M cash + $10M in pre-funded warrants); Hinova is eligible for up to ~$1.1B in development, regulatory & commercial… The post Evommune Enters Exclusive License Agreement with Hinova for EVO570, an Oral VAV1 Molecular Glue Degrader appeared first on PharmaShots.
PharmaShots
Nov 5, 2026, 11:07 AM
TJ Biopharma Reports P-II (PRIME-1) Data of Plonmarlimab for Macrophage Activation Syndrome
Shots: TJ Biopharma has announced publication of results from PRIME-1, a P-II study of plonmarlimab (anti-GM-CSF mAb) in macrophage activation syndrome (MAS), in the Journal of Hematology & Oncology In 18 glucocorticoid-refractory or relapsed MAS pts, Week-8 ORR was 83.3% (15/18), with median time to response of 2.1wks (earliest Day 5) & an LS-mean 79.3%… The post TJ Biopharma Reports P-II (PRIME-1) Data of Plonmarlimab for Macrophage Activation Syndrome appeared first on PharmaShots.
PharmaShots
Nov 5, 2026, 11:06 AM
Ono’s Sapablursen Receives the EC’s Orphan Medicinal Product Designation for Polycythemia Vera
Shots: Ono Pharmaceutical has reported that the European Commission has granted Orphan Medicinal Product Designation to sapablursen (ONO-0530) for polycythemia vera (PV) Sapablursen previously received US FDA Fast Track (Jan 2024), Orphan Drug (Aug 2024) & Breakthrough Therapy (May 2025) designations, plus Japan Orphan Drug Designation (Sep 2026) A trial-in-progress poster on the global P-III… The post Ono’s Sapablursen Receives the EC’s Orphan Medicinal Product Designation for Polycythemia Vera appeared first on PharmaShots.
PharmaShots
Nov 5, 2026, 11:02 AM
SK Biopharmaceuticals Submits sNDA to the US FDA for Cenobamate in Primary Generalized Tonic-Clonic Seizures
Shots: SK Biopharmaceuticals has submitted an sNDA to the US FDA seeking approval of cenobamate (Xcopri) for primary generalized tonic-clonic (PGTC) seizures & expansion of the existing focal-onset seizure indication to pediatric pts The PGTC filing is supported by a global P-III trial (NCT03678753; n=169 across 122 sites in 12 countries) in pts ≥12yrs., which… The post SK Biopharmaceuticals Submits sNDA to the US FDA for Cenobamate in Primary Generalized Tonic-Clonic Seizures appeared first on PharmaShots.
Pharma Tech
Nov 5, 2026, 10:49 AM
Podcast: An investor’s guide to preparing your clinical data package
Biotech investor Stephan Christgau speaks about the key considerations when devising a clinical strategy that will attract investor attention.
News
Latest industry coverage
Google News
Nov 5, 2026, 11:44 AM
PMi Awards 2026: innovation, connection and a changing industry - pharmaphorum
PMi Awards 2026: innovation, connection and a changing industry  pharmaphorum
Google News
Nov 5, 2026, 11:41 AM
Nxera's gut-targeted molecule nets $1.47bn from AbbVie - BioXconomy
Nxera's gut-targeted molecule nets $1.47bn from AbbVie  BioXconomy
Google News
Nov 5, 2026, 11:24 AM
Wuxi-developed cancer drug reaches US market - China Daily Global Edition
Wuxi-developed cancer drug reaches US market  China Daily Global Edition
Google News
Nov 5, 2026, 11:23 AM
Drug makers often sign CDMO renewals before they know when generics arrive - MarketScale
Drug makers often sign CDMO renewals before they know when generics arrive  MarketScale
Google News
Nov 5, 2026, 11:21 AM
Shilpa Medicare SHILPAMED NCLAT Sets Aside FTF Pharma CIRP Order - Kalkine India
Shilpa Medicare SHILPAMED NCLAT Sets Aside FTF Pharma CIRP Order  Kalkine India
Google News
Nov 5, 2026, 11:16 AM
Indian Companies Shine At Dubai International Industrial Exhibition, Thermolab’s Participation Highlights - Free Press Journal
Indian Companies Shine At Dubai International Industrial Exhibition, Thermolab’s Participation Highlights  Free Press Journal
Google News
Nov 5, 2026, 11:15 AM
Phillips Medisize Acquires Chippenham Facility to Expand Global Inhalation Center of Excellence - The National Law Review
Phillips Medisize Acquires Chippenham Facility to Expand Global Inhalation Center of Excellence  The National Law Review
Google News
Nov 5, 2026, 11:12 AM
Sun Pharma India sales rise 17.3% on volumes and launches - Multibagg AI
Sun Pharma India sales rise 17.3% on volumes and launches  Multibagg AI
Google News
Nov 5, 2026, 11:07 AM
Aurobindo Pharma Q2 net up 32.5% to â‚ą1,124 cr on higher revenue - The Hindu
Aurobindo Pharma Q2 net up 32.5% to ₹1,124 cr on higher revenue  The Hindu
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer